--- title: "NMPA Definition & Meaning | MedTech Terms" description: "China's regulatory authority for drugs, medical devices, and cosmetics. Plain-English Regulatory definition for MedTech teams, with examples and related terms." lang: en json-ld: | { "@context": "https://schema.org", "@graph": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/nmpa#term", "name": "National Medical Products Administration", "alternateName": "NMPA", "description": "NMPA (formerly CFDA) regulates the registration, manufacture, import, and post-market surveillance of medical devices in mainland China through a three-class risk-based framework.", "url": "https://medtechterms.com/terms/nmpa", "termCode": "nmpa", "inDefinedTermSet": { "@type": "DefinedTermSet", "name": "MedTech Terms", "url": "https://medtechterms.com/terms" } }, { "@type": "Article", "@id": "https://medtechterms.com/terms/nmpa#article", "headline": "NMPA, National Medical Products Administration", "description": "China's regulatory authority for drugs, medical devices, and cosmetics.", "url": "https://medtechterms.com/terms/nmpa", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://medtechterms.com/terms/nmpa" }, "about": { "@id": "https://medtechterms.com/terms/nmpa#term" }, "articleSection": "Regulatory", "inLanguage": "en", "keywords": "National Medical Products Administration, NMPA, Regulatory, medical device, MedTech", "author": { "@type": "Person", "name": "Christian Espinosa", "jobTitle": "Founder, Blue Goat Cyber", "url": "https://bluegoatcyber.com" }, "publisher": { "@type": "Organization", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "isPartOf": { "@type": "WebSite", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "datePublished": "2026-05-05", "dateModified": "2026-05-05", "citation": [ { "@type": "CreativeWork", "name": "NMPA English portal", "url": "https://english.nmpa.gov.cn/", "publisher": { "@type": "Organization", "name": "NMPA" } }, { "@type": "CreativeWork", "name": "FDA - Medical Devices", "url": "https://www.fda.gov/medical-devices", "publisher": { "@type": "Organization", "name": "FDA" } }, { "@type": "CreativeWork", "name": "European Commission - Medical Devices", "url": "https://health.ec.europa.eu/medical-devices-sector_en", "publisher": { "@type": "Organization", "name": "European Commission" } } ], "mentions": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/imdrf#term", "name": "IMDRF", "url": "https://medtechterms.com/terms/imdrf" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/mdsap#term", "name": "Medical Device Single Audit Program", "alternateName": "MDSAP", "url": "https://medtechterms.com/terms/mdsap" } ] }, { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://medtechterms.com/" }, { "@type": "ListItem", "position": 2, "name": "Terms", "item": "https://medtechterms.com/terms" }, { "@type": "ListItem", "position": 3, "name": "Regulatory", "item": "https://medtechterms.com/terms?cat=Regulatory" }, { "@type": "ListItem", "position": 4, "name": "National Medical Products Administration", "item": "https://medtechterms.com/terms/nmpa" } ] }, { "@type": "FAQPage", "@id": "https://medtechterms.com/terms/nmpa#faq", "mainEntity": [ { "@type": "Question", "name": "What is the NMPA's classification system for medical devices?", "acceptedAnswer": { "@type": "Answer", "text": "The NMPA uses a three-class risk-based classification system, similar to many other regulatory bodies. Class I devices pose low risk, Class II devices pose medium risk, and Class III devices pose high risk to patients and users." } }, { "@type": "Question", "name": "Are foreign manufacturers required to have a local agent in China?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, foreign manufacturers are generally required to appoint a legal agent based in mainland China. This agent is responsible for submissions, communication with NMPA, and other in-country regulatory activities." } }, { "@type": "Question", "name": "What is the 'innovative device' fast track?", "acceptedAnswer": { "@type": "Answer", "text": "The innovative device fast track is a special pathway designed to expedite the review and approval process for novel medical devices that meet specific criteria for innovation and clinical value, as defined by NMPA guidelines." } } ] } ] } --- [ MedTech Terms The authoritative reference ](/) Browse Learn [Latest](/latest) About 1. [Home](/) 2. / 3. [Terms](/terms) 4. / 5. [Regulatory](/terms?cat=Regulatory) 6. / 7. National Medical Products Administration [All terms](/terms) Regulatory [Regulated Pathways](/ecosystems/regulated-pathways)[Global Markets](/ecosystems/global-markets)NMPA # National Medical Products Administration China's regulatory authority for drugs, medical devices, and cosmetics. Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 ## Definition NMPA (formerly CFDA) regulates the registration, manufacture, import, and [post-market surveillance](/terms/post-market-surveillance) of medical devices in mainland China through a three-class risk-based framework. What the regulation says The National Medical Products Administration (NMPA) operates under the direct leadership of the State Administration for Market Regulation (SAMR) and is responsible for drug (including active pharmaceutical ingredients, excipients), medical device, and cosmetic regulation in mainland China. The NMPA's regulatory framework for medical devices is outlined in various NMPA orders and decrees, such as NMPA Order 659, which details medical device registration and filing administration. This framework dictates requirements for product registration, clinical evaluation, and [post-market surveillance](/terms/post-market-surveillance). ## What this means in practice Most Class II and III devices require in-country clinical evaluation or trials, type testing at NMPA-designated labs, and a local agent. Recent reforms have introduced an innovative-device fast track and accept some overseas data. ## Examples - A European MedTech company seeking to market its Class II surgical robot in China must first go through NMPA type testing at a designated NMPA laboratory and appoint a local legal agent. - A manufacturer of a novel Class III implantable device applies for the NMPA innovative device fast track, demonstrating its significant clinical benefit and technological breakthrough compared to existing options. - A US-based company selling diagnostic reagents in China undergoes an NMPA post-market surveillance audit, where the NMPA reviews its quality management system and compliance with Chinese regulations. Common pitfalls - • A common pitfall is underestimating the need for local representation and testing, which are often mandatory for foreign manufacturers. - • Manufacturers sometimes misunderstand the specific criteria for the "innovative device" fast track, leading to incorrect application strategies. - • Failing to keep up with frequently updated NMPA regulations and guidance documents can result in compliance issues. - • Assuming that international certifications or clinical data are always directly accepted without NMPA-specific review or bridging studies is a frequent mistake. - • Inadequate preparation for NMPA on-site audits and inspections can lead to delays or non-compliance findings. ## Frequently asked questions What is the NMPA's classification system for medical devices? The NMPA uses a three-class risk-based classification system, similar to many other regulatory bodies. Class I devices pose low risk, Class II devices pose medium risk, and Class III devices pose high risk to patients and users. Are foreign manufacturers required to have a local agent in China? What is the 'innovative device' fast track? ## Related terms Grouped by theme ### Editor's picks · Hand-selected related concepts [ Regulatory IMDRF International Medical Device Regulators Forum. ](/terms/imdrf)[ Quality & Risk Medical Device Single Audit Program(MDSAP) Single audit of a manufacturer's QMS satisfying multiple participating regulators. ](/terms/mdsap) ### More in Regulatory · Same category [ Regulatory 510(k) Premarket Notification(510(k)) FDA submission demonstrating a device is substantially equivalent to a legally marketed predicate. ](/terms/510k)[ Regulatory 510(k) Summary vs 510(k) Statement Two alternative disclosure mechanisms in a 510(k) submission, a Summary is public on FDA's website; a Statement promises to share Safety & Effectiveness info on request. ](/terms/510k-summary-vs-statement)[ Regulatory 513(g) Request for Information(513(g)) Formal mechanism to ask FDA whether a product is a device and, if so, its likely classification. ](/terms/513g)[ Regulatory Abbreviated 510(k) 510(k) variant that relies on FDA guidance, special controls, or recognized consensus standards. ](/terms/abbreviated-510k) Cited by Where this term appears across MedTech Terms. Ecosystems (2) - [Regulated Pathways](/ecosystems/regulated-pathways) - [Global Markets](/ecosystems/global-markets) ## Primary references 3 sources Link health: 3 verified · last checked 2026-06-20 NMPA· 1 FDA· 1 European Commission· 1 1. [1 NMPA English portal Verified NMPA · english.nmpa.gov.cn ](https://english.nmpa.gov.cn/) 2. [2 FDA - Medical Devices Verified FDA · fda.gov ](https://www.fda.gov/medical-devices) 3. [3 European Commission - Medical Devices Verified European Commission · health.ec.europa.eu ](https://health.ec.europa.eu/medical-devices-sector_en) Inline markers like \[1\] jump to the matching reference above. Sponsor note ### Navigating an FDA or EU MDR submission? Blue Goat Cyber supports the cybersecurity content of premarket submissions, from threat models to the 524B narrative. [Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session) - No obligation - Expert-led from minute one - NDA available on request MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor. On this term Category Regulatory Acronym NMPA Sources 3 Updated 5/5/2026 [Compare with another term](/compare?a=nmpa) Learn in 60 seconds Card Lesson Quiz China's regulatory authority for drugs, medical devices, and cosmetics. - · Most Class II and III devices require in-country clinical evaluation or trials, type testing at NMPA-designated labs, and a local agent. - · Recent reforms have introduced an innovative-device fast track and accept some overseas data. Remember this Watch out: A common pitfall is underestimating the need for local representation and testing, which are often mandatory for foreign manufacturers. Related terms - [IMDRF ](/terms/imdrf) - [Medical Device Single Audit Program(MDSAP) ](/terms/mdsap) You may also need Auto-suggested from Regulatory and shared keywords. - [ANVISA(ANVISA) ](/terms/anvisa) - [EU In Vitro Diagnostic Regulation(IVDR) ](/terms/ivdr) - [MHRA / UKCA Marking(MHRA / UKCA) ](/terms/mhra-ukca) - [Ministry of Food and Drug Safety (Korea)(MFDS) ](/terms/mfds) - [Person Responsible for Regulatory Compliance(PRRC) ](/terms/prrc) - [Pharmaceuticals and Medical Devices Agency(PMDA) ](/terms/pmda) [All Regulatory terms](/terms?cat=Regulatory) From the Blue Goat network Related resources and services on this topic. - [ MedTech Cybersecurity Standards Authoritative reference for the standards and guidances behind medical device cybersecurity. ](https://medtechcyberstandards.com) - [ MedTech Cybersecurity Crosswalk International crosswalk of medical device cybersecurity requirements across regulators. ](https://mdccrosswalk.com) - [ MedTech Truths Common misconceptions about medical device development - debunked. ](https://mdcmisconceptions.com) - [ MedTech Launchpad MedTech funding rounds, accelerators, and launch resources. ](https://medtechlaunchguide.com) MedTech Terms An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices. Browse - [All terms](/terms) - [A–Z index](/a-z) - [Categories](/categories) - [Ecosystems](/ecosystems) - [Learning paths](/paths) - [Compare terms](/compare) - [Quiz](/quiz) Resources - [FDA Medical Devices](https://www.fda.gov/medical-devices) - [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj) - [IMDRF](https://www.imdrf.org/) - [Methodology](/methodology) - [Changelog](/changelog) - [Editor: Christian Espinosa](/authors/christian-espinosa) - [About this site](/about) © 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)